Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can tape and buzzes beat shoulder pain? new study hopes to find out

NCT ID NCT06409442

Symptom relief Sponsor: Dokuz Eylul University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding kinesio taping or local vibration therapy to a standard 6-week physiotherapy program can help people with chronic shoulder pain (subacromial pain syndrome). Sixty-three adults will be split into three groups: one gets standard rehab alone, one adds taping, and one adds vibration. Researchers will measure pain, movement, strength, and quality of life over 24 weeks to see if the extra treatments make a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
kinesio taping and local vibration therapy
What this could lead to
If successful, this could point toward simple, non-drug additions to physical therapy that reduce shoulder pain and improve daily function.
What could go wrong
This is a small, early-stage trial with only 63 participants, so results may not apply to everyone. The added treatments may not provide extra benefit over standard physiotherapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 63 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Volunteering to participate in the study, * Being over 18 years of age, * Having diagnosed with subacromial impingement syndrome, * SIS-related complaints have persisted for at least 3 months, * Not having received any treatment for shoulder problems in the last 6 months, * No history of shoulder injury other than subacromial impingement and/or shoulder symptoms requiring treatment for the last 1 year, * To be able to read and write Turkish in order to complete all evaluations and applications in the study and to carry out evaluations that require reading and writing. Exclusion Criteria: * Having a history of fractures and surgery in the upper extremity and cervicothoracic region, * Having another neurological, orthopedic or rheumatic shoulder problem such as frozen shoulder or instability, * Having a systemic musculoskeletal disease, * Known chest deformity, scoliosis diagnosis and physical disability, * Presence of a skin problem or a condition that may be a contraindication to the application in the area where KT or LVT will be applied.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Subacromial pain syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain shoulder impingement syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Subacromial pain syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dokuz Eylül University

    RECRUITING

    Izmir, Balçova, 35330, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.